Biocept Inc expected to post a loss of 19  cents a share - Earnings Preview

Biocept

29/03/2022 22:40

* Biocept Inc  BIOC.OQ   BIOC.O  is expected to show a fall
in
quarterly revenue when it reports  results on March 31. 
    * The San Diego California-based  company is expected to
report  a
40.0% decrease in revenue to $11.108 million from $18.51 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Biocept Inc is for
a loss
of 19 cents per share. For the same quarter last year, the
company reported earnings of 14 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Biocept Inc
is
$10.5​, above​ its last closing price of $2.23. ​​​

This summary was machine generated March 29 at 21:40 GMT.  All
figures in US dollars  unless otherwise stated